Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

POLY MEDICURE LTD. - 531768 - Board Meeting Intimation for Intimation Of Notice Of Board Meeting To Be Held On 7Th August, 2023

 POLY MEDICURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2023 ,inter alia, to consider and approve Pursuant to the provisions of Regulation 29(1)(a) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Notice is hereby given that the meeting of the Board of Directors of the Company will be held on Monday, the 7th day of August, 2023 inter-alia to consider the following: To consider and approve Standalone and Consolidated Un-audited IND-AS compliant Financial Results along with Limited Review Report for the quarter ended 30 June, 2023 pursuant to regulation 33 of Listing Obligation and Disclosure Requirement, 2015. To transact any other matter which the Board may deem fit. In continuation of our intimation regarding closure of trading window, the Trading Window for dealing in securities of the Company shall remain closed till 9th August, 2023.
26-07-2023
Bigul

POLY MEDICURE LTD. - 531768 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 In terms of Regulation 74(5) of SEBI(Depositories and Participants) Regulations, 2018, we enclose herewith the confirmation certificate received from M/s Mas Services Limited, Registrar & Share Transfer Agent of the Company for the quarter ended 30th June, 2023.
17-07-2023
Bigul

POLY MEDICURE LTD. - 531768 - Increase In Volume

 With reference to your email ref no.: L/SURV/ONL/PV/VK/2023-24/196, dated 13th July, 2023, seeking clarification in respect of significant increase in the volume of the Company''s security across exchanges, in the recent past. In this regard we wish to inform you that, there is no information and/or announcement (including impending announcement) which in our opinion may have a bearing on the Price/volume behavior of the Company''s scrip as traded across exchanges and which is required to be informed to stock exchanges in terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Therefore, whatever the movement in volume of the company''s security is purely due to market conditions and absolutely market driven.
13-07-2023
Bigul

POLY MEDICURE LTD. - 531768 - Clarification sought from Poly Medicure Ltd

 The Exchange has sought clarification from Poly Medicure Ltd on July 13, 2023, with reference to Movement in Volume.The reply is awaited.
13-07-2023
Bigul

POLY MEDICURE LTD. - 531768 - Closure of Trading Window

 It may be noted that in compliance with SEBI(Prohibition to Insider Trading) Regulations, 2015 as amended by the SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018 read with clarification given by BSE Circular Ref No.: LIST/COMP/01/2019-20 dated 02.04.2019 and NSE letter ref No: NSE/CML/2019/11 dated 02.04.2019 read with Company''s Code of Conduct for prevention of Insider Trading, the Trading Window of the Company has been kept closed for designated person from Saturday, the 01st July, 2023 till the end of 48 hours after the declaration of Financial Results for the quarter ended on 30th June, 2023.
30-06-2023
Bigul

POLY MEDICURE LTD. - 531768 - Increase In Volume

 With reference to your e-mail ref.: L/SURV/ONL/PV/VK/2023-2024/152, dated 16th June, 2023, seeking clarification in respect of significant increase in the volume of the Company''s security across exchanges, in the recent past. In this regard we wish to inform you that, there is no information and/or announcement (including impending announcement) which in our opinion may have a bearing on the Price/Volume behavior of the Company''s Scrip as traded across exchanges and which is required to be informed to stock exchanges in terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Therefore, whatever the movement in volume of the Company's security is purely due to market conditions and absolutely market driven. Further kindly note that, the Company has been regularly disseminating unpublished price sensitive information as and when required in terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
16-06-2023
Bigul

POLY MEDICURE LTD. - 531768 - Clarification sought from Poly Medicure Ltd

 The Exchange has sought clarification from Poly Medicure Ltd on June 16, 2023, with reference to Movement in Volume.The reply is awaited.
16-06-2023
Bigul

POLY MEDICURE LTD. - 531768 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Dear Sir/Madam, Pursuant to Regulation 24(a) of SEBI (LODR) Regulations, 2015, We enclose herewith Annual Secretarial Compliance Report of the Company for the financial year ended 31st March, 2023 by P. K. Mishra & Associates, Practising Company Secretaries.
25-05-2023
Bigul

POLY MEDICURE LTD. - 531768 - Declaration Of Impact Of Un-Modified Audit Qualifications(Standalone & Consolidated) In Compliance Of Regulation 33(3)(D) Of SEBI(LODR) Regulations, 2015.

 In Compliance of Regulation 33(3)(d) of SEBI (LODR) Regulations, 2015, We hereby declare that M/ s. M.C. Bhandari & Company, Statutory Auditors of the Company have issued Audit Report with un-modified opinion on the Audited Financial Results (Standalone & Consolidated) for the fourth quarter and financial year ended on 31st March, 2023.
09-05-2023
Bigul

POLY MEDICURE LTD. - 531768 - Disclosure Of Related Party Transactions For The Year Ended March 31, 2023

 Pursuant to Regulation 23(9) of Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed herewith disclosures of Related Party Transactions for the year ended March 31, 2023.
09-05-2023
Next Page
Close

Let's Open Free Demat Account